Evidence map›Paper›PMID 36704147›Full record

ArticleFrontiers in pediatrics2022

Novel homozygous silent mutation of

Zhengrong Wang, Yuqing Xu, Yixi Sun, Shuang Wang, Minyue Dong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Observational
  3. Synonymous Variants of Uncertain Silence.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Zhengrong WangSchool of Clinical Laboratory Science, Guizhou Medical University, Guiyang, China.
Yuqing XuWomen's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Yixi SunWomen's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Shuang WangSchool of Clinical Laboratory Science, Guizhou Medical University, Guiyang, China.
Minyue DongWomen's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Affiliated Hospital of Guizhou Medical University · CNMinistry of Education of the People's Republic of China · CNWomen's Hospital, School of Medicine, Zhejiang University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glanzmann thrombasthenia (GT) is a rare inherited disease characterized by mucocutaneous bleeding due to the abnormalities in quantity or quality of platelet membrane GP IIb (CD41) or GP IIIa (CD61). GP IIb and GP IIIa are encoded by the

Indexed as

Glanzmann thrombastheniaintegrin αIIbβ3ITGB3silent mutationwhole exome sequencing

Identifiers

PMID36704147
PMCPMC9871544
OpenAlexW4315434011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.